Results 1 to 10 of about 1,682,964 (357)
Background Idiopathic pulmonary fibrosis (IPF) and chronic hypersensitivity pneumonitis share commonalities in pathogenesis shifting haemostasis balance towards the procoagulant and antifibrinolytic activity.
Małgorzata Sobiecka +10 more
doaj +1 more source
Sudden Vision Loss Due to Optic Neuritis—An Uncommon Presentation of Neurosarcoidosis
Sarcoidosis is a systemic, granulomatous disease of unknown etiology, most often manifested by mediastinal and hilar lymph node enlargement and parenchymal nodules in the lungs. However, it may involve any other organ. Neuro-sarcoidosis, a condition that
Katarzyna Zimna +5 more
doaj +1 more source
Fibrinolytic Therapy in Purulent Pericarditis
Purulent pericarditis (PP) is rare disease, and if left untreated, it is associated with very high mortality, nearly 100%. A considerable clinical problem due to PP is a very high probability of developing constrictive pericarditis (CP).
Małgorzata Dybowska +4 more
doaj +1 more source
Acute Eosinophilic Pneumonia (AEP) is a rare idiopathic disease caused by an accumulation of eosinophils in the pulmonary alveoli and interstitial tissue of the lungs. The onset of symptoms is acute; some patients develop respiratory failure.
Ewa Jankowska +6 more
doaj +1 more source
An Unfavorable Outcome of M. chimaera Infection in Patient with Silicosis
Mycobacterium chimaera is a slow-growing, nontuberculous mycobacterium (NTM) belonging to the Mycobacterium avium complex (MAC). It was identified as a unique species in 2004.
Ewa Łyżwa +8 more
doaj +1 more source
Background: Fibrotic hypersensitivity pneumonitis (fHP) shares many features with other fibrotic interstitial lung diseases (ILD), and as a result it can be misdiagnosed as idiopathic pulmonary fibrosis (IPF).
Małgorzata Sobiecka +10 more
doaj +1 more source
The six-minute-walking test (6MWT) is an easy-to-perform, cheap and valuable tool to assess the physical performance of patients. It has been used as one of the endpoints in many clinical trials investigating treatment efficacy in pulmonary arterial ...
Katarzyna B. Lewandowska +8 more
doaj +1 more source
A Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) led to a pandemic outbreak in 2019. COVID-19’s course and its treatment in immunocompromised patients are uncertain.
E. Łyżwa +8 more
doaj +1 more source
Intrapericardial recombinant tissue plasminogen activator in purulent pericarditis- case series
Background Pericardial constriction is one of the complications of purulent pericarditis (PP). Most difficult to treat, which may develop both in early and in the late period of the disease, resulting in a very poor prognosis.
Małgorzata Dybowska +4 more
doaj +1 more source
Background: Cystic fibrosis (CF) is an autosomal, recessive genetic disorder, caused by a mutation in the cystic fibrosis transmembrane conductance receptor regulator (CFTR) gene.
Dorota Wyrostkiewicz +6 more
doaj +1 more source

